Skip to content
Review Open access

Functionalization of Nanozymes: A Precision Approach to Targeted Cancer Therapy.

Jul 2026 · ACS Biomaterials Science & Engineering · Vol 12 8, pp. 3907-3944 · 0 citations · 276 references
Medicine

TL;DR

Different functionalization strategies, including covalent, noncovalent, and peptide-, ligand-, and aptamer-based approaches, will be highlighted to enhance targeting, catalytic efficiency, and clinical applicability.

Abstract

Nanozymes are nanoscale materials that function similarly to natural enzymes, offering advantages for cancer therapy when compared with traditional biological enzymes due to their enhanced enzymatic activity, stability, versatility, low cost, and their ability to alter the tumor microenvironment. This enables new cancer treatment strategies by modulating the tumor microenvironment through chemotherapy, photothermal therapy, photodynamic therapy, or starving therapy. However, challenges persist that hinder the development and use of nanozymes for cancer treatment, including difficulties in substrate selection, ongoing issues of tumor microenvironment heterogeneity, and the risk of off-target toxicities. Therefore, developing functionalization strategies to enhance nanozyme catalytic efficiency, targeting specificity, and biocompatibility can significantly enhance the success of novel nanozymes in cancer treatment. The covalent techniques for attaching peptides, polymers, and aptamers are based on EDC/NHS coupling, Click chemistry, and Schiff-base condensation. Noncovalent attachment techniques rely on reversible interactions (e.g., hydrogen bonds, π-π stacking, and electrostatic forces) to retain the native enzyme activity. While functionalization techniques improve the tumor targeting and biodistribution of nanozymes, they also enable stimulus-responsive activation of the nanozymes in the tumor microenvironment (triggered by acidic pH, glutathione, and/or H2O2) to reduce the risk of systemic toxicity. This review comprehensively discusses the classification, catalytic principles, and therapeutic applications of nanozymes, with emphasis on their role in modulating the tumor microenvironment for effective cancer therapy. Different functionalization strategies, including covalent, noncovalent, and peptide-, ligand-, and aptamer-based approaches, will be highlighted to enhance targeting, catalytic efficiency, and clinical applicability.

Read PDF

Similar papers

Review Open access Aug 2026

Piezoelectric nanozymes: a new frontier for next-generation tumor therapeutics

Piezoelectric nanozymes offer a versatile platform for multimodal cancer therapy and represent a promising paradigm for developing strategies for precise, non-invasive cancer therapy through localized ROS generation and modulation of the TME.

Akanksha Deshwal, A. Vimal, Prachi Nirwan et al. · 0 citations
Review Aug 2026

Biomimetic cell-membrane-coated metallic nanoparticles in cancer therapy: Design, functional mechanisms, and translational challenges.

Cancer remains a major health concern worldwide, with the need to identify better and more specific treatment measures. The concept of using metallic nanoparticles in drug delivery has attracted significant attention due to their distinct physicochemical characteristics, including surface area, size, and multifunctiona...

Hiti Narula, R. Kamal, Thakur Gurjeet Singh et al. · 1 citation
Review Open access Sep 2026

Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches

This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...

C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al. · 0 citations
Review Open access Aug 2026

Stimuli-responsive bioengineered platforms for precision cancer therapy

The evidence supports a conceptual transition from passive nanocarriers to programmable therapeutic systems capable of aligning therapeutic action with the spatial, temporal, and biological heterogeneity of tumors, but translation remains constrained by formulation complexity, incomplete standardization, limited long-t...

Hamid Omidian, Renae L. Wilson · 1 citation
Review Aug 2026

Dendrimer-Based Nanoplatforms for Cancer Diagnosis and Therapy: from Liquid Biopsy to Targeted Protein Degradation

Dendrimer-based systems have shown considerable potential to remodel the tumor microenvironment, induce immunogenic cell death, enhance immune activation, and facilitate combination therapies, offering promising opportunities to improve cancer diagnosis, treatment, and patient outcomes.

Mahsa Hasannejad Alibaglou, Zeinab Chaharlashkar, Fateme Bina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.